Xopenex and Genotropin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xopenex (levalbuterol hydrochloride) and Genotropin (somatropin recombinant). Common drug interactions include arthralgia among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Xopenex and Genotropin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.

What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 41,924 Genotropin users. Check the latest studies of Genotropin.



On Jul, 07, 2026

23 people who take Xopenex and Genotropin together, and have interactions are studied.

Xopenex and Genotropin drug interactions.

What are the common drug interactions of Xopenex and Genotropin, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Headache (pain in head)
  3. Memory impairment
  4. Blood oestrogen increased
  5. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  6. Asthenia (weakness)
  7. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  8. Blood prolactin increased
  9. C-reactive protein increased
  10. Constipation

male:

  1. Headache (pain in head)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Diarrhoea
  4. Growth retardation (delayed growth)
  5. Hallucination, auditory (perceiving sounds without auditory stimulus)
  6. Influenza
  7. Initial insomnia (feeling of inadequate or poor-quality sleep)
  8. Limb asymmetry (consistent task discrepancy between the two lower limbs)
  9. Pain in extremity
  10. Concussion (short loss of normal brain function in response to a head injury)

What are the common drug interactions of Xopenex and Genotropin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Headache (pain in head)
  2. Croup infectious (a loud cough that resembles the barking of a seal and difficulty breathing can transfer to other)
  3. Immune system disorder
  4. Increased appetite
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Pain
  7. Upper limb fracture
  8. Concussion (short loss of normal brain function in response to a head injury)
  9. Road traffic accident
  10. Blood oestrogen increased

10-19:

  1. Headache (pain in head)
  2. Abnormal behaviour
  3. Acne (skin problems that cause pimples)
  4. Constipation
  5. Diarrhoea
  6. Growth retardation (delayed growth)
  7. Hallucination, auditory (perceiving sounds without auditory stimulus)
  8. Influenza
  9. Initial insomnia (feeling of inadequate or poor-quality sleep)
  10. Limb asymmetry (consistent task discrepancy between the two lower limbs)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Arthralgia (joint pain)
  2. Asthenia (weakness)
  3. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  4. Night sweats (sweating in night)
  5. Red cell distribution width increased
  6. Blood prolactin increased
  7. C-reactive protein increased
  8. Constipation
  9. Headache (pain in head)
  10. Hypersensitivity

What are the existing conditions these people have? *

  1. Hypersensitivity: 9 people, 39.13%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 21.74%
  3. Body Height Below Normal: 5 people, 21.74%
  4. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 4 people, 17.39%
  5. Developmental Delay: 4 people, 17.39%
  6. Nausea And Vomiting: 3 people, 13.04%
  7. Nausea (feeling of having an urge to vomit): 3 people, 13.04%
  8. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 3 people, 13.04%
  9. Pain: 2 people, 8.70%
  10. Failure To Thrive (inadequate weight gain and physical growth in children): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex and Genotropin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xopenex and Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xopenex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Genotropin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levalbuterol hydrochloride and somatropin recombinant (the active ingredients of Xopenex and Genotropin, respectively), and Xopenex and Genotropin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: